Microbot Medical Inc.
MBOT
$2.34
-$0.14-5.65%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.56M | 3.12M | 1.24M | 1.09M | 1.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.02M | 3.43M | 3.30M | 2.51M | 2.38M |
| Operating Income | -3.02M | -3.43M | -3.30M | -2.51M | -2.38M |
| Income Before Tax | -2.60M | -3.39M | -3.22M | -2.47M | -2.37M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.60M | -3.39M | -3.22M | -2.47M | -2.37M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.60M | -3.39M | -3.22M | -2.47M | -2.37M |
| EBIT | -3.02M | -3.43M | -3.30M | -2.51M | -2.38M |
| EBITDA | -3.01M | -3.40M | -3.28M | -2.50M | -2.36M |
| EPS Basic | -0.08 | -0.20 | -0.20 | -0.17 | -0.17 |
| Normalized Basic EPS | -0.06 | -0.12 | -0.12 | -0.10 | -0.11 |
| EPS Diluted | -0.08 | -0.20 | -0.20 | -0.17 | -0.17 |
| Normalized Diluted EPS | -0.06 | -0.12 | -0.12 | -0.10 | -0.11 |
| Average Basic Shares Outstanding | 31.09M | 17.19M | 16.47M | 14.85M | 14.06M |
| Average Diluted Shares Outstanding | 31.09M | 17.19M | 16.47M | 14.85M | 14.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |